Pharmaceutical Company Finalizes $3M Exclusive Global Out-Licensing Agreement For Pain Therapy Treatment
SciSparc Ltd.'s Out-Licensing Agreement with Polyrizon Ltd.: A New Chapter in Pain Management.
Disclaimer: The following article is intended for informational purposes only and does not constitute financial advice, medical advice, or an endorsement of any products or companies mentioned herein.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members …